vx-745 has been researched along with mevastatin in 1 studies
| Studies (vx-745) | Trials (vx-745) | Recent Studies (post-2010) (vx-745) | Studies (mevastatin) | Trials (mevastatin) | Recent Studies (post-2010) (mevastatin) |
|---|---|---|---|---|---|
| 58 | 1 | 35 | 495 | 3 | 67 |
| Protein | Taxonomy | vx-745 (IC50) | mevastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0484 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.119 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.119 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.134 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egbert, M; Keserű, GM; Vajda, S; Whitty, A | 1 |
1 other study(ies) available for vx-745 and mevastatin
| Article | Year |
|---|---|
Why Some Targets Benefit from beyond Rule of Five Drugs.
Topics: Binding Sites; Drug Discovery; Ligands; Molecular Weight; Protein Binding | 2019 |